A detailed history of Blankinship & Foster, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Blankinship & Foster, LLC holds 11,969 shares of ABT stock, worth $1.41 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares
11,969
Previous 11,969 -0.0%
Holding current value
$1.41 Million
Previous $1.36 Million 8.6%
% of portfolio
0.32%
Previous 0.36%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022

BUY
$102.07 - $123.37 $76,552 - $92,527
750 Added 6.69%
11,969 $1.3 Million
Q4 2021

Feb 09, 2022

SELL
$115.53 - $141.46 $3,696 - $4,526
-32 Reduced 0.28%
11,219 $1.58 Million
Q3 2020

Nov 10, 2020

BUY
$91.64 - $111.29 $1.03 Million - $1.25 Million
11,251 New
11,251 $1.22 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Blankinship & Foster, LLC Portfolio

Follow Blankinship & Foster, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blankinship & Foster, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Blankinship & Foster, LLC with notifications on news.